Computed Tomography Coronary Angiography for the Prevention of Myocardial Infarction (The SCOT-HEART 2 Trial)

NCT03920176 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6139

Last updated 2026-01-15

No results posted yet for this study

Summary

It is hypothesised that, in individuals being considered for cardiovascular preventative therapy, computed tomography coronary angiography guided management will reduce the future risk of coronary heart disease death or non-fatal myocardial infarction compared to management guided by the current standard of care, a cardiovascular risk score.

Conditions

  • Cardiovascular Diseases

Interventions

DIAGNOSTIC_TEST

Computed tomography coronary angiography

CTCA \>64 detector row scanner

OTHER

ASSIGN Score

ASSIGN Cardiovascular Risk Score

Sponsors & Collaborators

  • British Heart Foundation

    collaborator OTHER
  • NHS Lothian

    collaborator OTHER_GOV
  • University of Edinburgh

    lead OTHER

Principal Investigators

  • David E Newby · University of Edinburgh

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-13
Primary Completion
2025-12-19
Completion
2028-12-31

Countries

  • United Kingdom

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03920176 on ClinicalTrials.gov